Source: Endpoints News

A2 Bio received $80M in Series C Funding

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

CEO

James Robinson

CEO Approval Rating

83/100

A2 Bio is a California-based biotechnology company that researches and develops T-cell therapies for the treatment of cancer.